Related Experiment Video
Updated: May 4, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
The Impact of Left Ventricular Hypertrophy and Diastolic Dysfunction on Outcome in Intracerebral Hemorrhage Patients
Karen C Albright1, Joshua M Burak2, Tiffany R Chang3
1Health Services and Outcomes Research Center for Outcome and Effectiveness Research and Education (COERE), University of Alabama at Birmingham, Birmingham, AL 35294-4410, USA ; Center of Excellence in Comparative Effectiveness Research for Eliminating Disparities (CERED) Minority Health & Health Disparities Research Center (MHRC), University of Alabama at Birmingham, Birmingham, AL 35294-4410, USA ; School of Public Health, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294-0022, USA.
Insights
Left ventricular hypertrophy (LVH) and diastolic dysfunction (DD) were studied in patients with deep intracerebral hemorrhage (ICH). LVH and DD did not predict ICH volume, expansion, or poor outcomes, though LVH was linked to IVH.
Area of Science:
- Neurology
- Cardiology
- Radiology
Background:
- Deep intracerebral hemorrhage (ICH) is a significant cause of neurological deficit.
- Left ventricular hypertrophy (LVH) and diastolic dysfunction (DD) are common cardiovascular conditions.
- The relationship between cardiac abnormalities and ICH outcomes requires further elucidation.
Purpose of the Study:
- To determine the prevalence of LVH and DD in patients with supratentorial deep ICH.
- To assess if LVH or DD independently predict initial ICH volume, hematoma expansion, or poor outcomes.
Main Methods:
- Cross-sectional study of ICH patients (7/2008-12/2010).
- Exclusion criteria included traumatic, lobar, infratentorial ICH, elevated INR, structural malformations, or prior surgery.
- Logistic and linear regressions analyzed LVH/DD as predictors of ICH characteristics and outcomes.
Main Results:
- LVH was not a significant independent predictor of initial ICH volume (P=0.344) or 33% volume expansion (P=0.378) after adjusting for hemostatic agents.
- LVH was not a significant independent predictor of poor functional outcome (P=0.778) after adjusting for age, infections, and hemostatic agents.
- Similar non-significant findings were observed for DD.
Conclusions:
- In patients with deep ICH, LVH was associated with a higher likelihood of developing intraventricular hemorrhage (IVH).
- LVH was not found to be an independent predictor of initial ICH volume, hematoma expansion, or poor short-term functional outcomes.
- Diastolic dysfunction (DD) also did not independently predict these adverse ICH-related events.
Background:
The objective of this study was to determine the prevalence of LVH and DD in patients presenting with supratentorial deep ICH and to determine if the presence of LVH or DD was an independent predictor of initial ICH volume, hematoma expansion, or poor outcome.
Methods:
A cross-sectional study was performed on ICH patients who presented from 7/2008 to 12/2010. Cases were excluded if ICH was traumatic, lobar, infratentorial, secondary to elevated international normalized ratio, suspicious for underlying structural malformation, or where surgical evacuation was performed. Logistic and linear regressions were used to assess the ability of LVH to predict ICH imaging characteristics and patient outcomes.
Results:
After adjusting for use of hemostatic agents, LVH was not a significant independent predictor of initial ICH volume (P = 0.344) or 33% volume expansion (P = 0.378). After adjusting for age, infectious complications, and use of hemostatic agents, LVH was not a significant independent predictor of poor functional outcome (P = 0.778). Similar results were seen for DD.
Conclusion:
In our sample, patients with deep ICH and LVH were more likely to develop IVH, but LVH was not a significant independent predictor of initial ICH volume, hematoma expansion, or poor short-term outcome.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

